{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T06:10:29Z","timestamp":1718086229986},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T00:00:00Z","timestamp":1442620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00108-015-3763-3","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T11:04:56Z","timestamp":1442487896000},"page":"1196-1208","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arzneimitteltherapie der Alopezien","Drug treatment of alopecia"],"prefix":"10.1007","volume":"56","author":[{"given":"H.","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,19]]},"reference":[{"key":"3763_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/aja.1000710306","volume":"71","author":"Hamilton","year":"1942","unstructured":"Hamilton JB (1942) Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 71:451\u2013480","journal-title":"Am J Anat"},{"key":"3763_CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/431425","volume":"77","author":"Hillmer","year":"2005","unstructured":"Hillmer AM et\u00a0al (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 77(1):140\u2013148","journal-title":"Am J Hum Genet"},{"key":"3763_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-0960.2011.00745.x","volume":"52","author":"Yip","year":"2011","unstructured":"Yip L, Rufaut N, Sinclair R (2011) Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol 52(2):81\u201388","journal-title":"Australas J Dermatol"},{"key":"3763_CR4","unstructured":"Wolff H, Kunte C (1999) Die androgenetische Alopezie des Mannes \u2013 Pathogenese und Therapie. Z\u00a0Hautkr 74:201\u2013208"},{"key":"3763_CR5","doi-asserted-by":"crossref","unstructured":"Kaufman KD et\u00a0al (1998) Finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J\u00a0Am Acad Dermatol 36:578\u2013589","DOI":"10.1016\/S0190-9622(98)70007-6"},{"key":"3763_CR6","first-page":"38","volume":"12","author":"Finasteride","year":"2002","unstructured":"Finasteride Male Pattern Hair Loss Study Group (2002) Long-term (5-year) multinational experience with finasteride 1\u00a0mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 12:38\u201349","journal-title":"Eur J Dermatol"},{"key":"3763_CR7","first-page":"150","volume":"13","author":"Whiting","year":"2003","unstructured":"Whiting DA et\u00a0al (2003) Efficacy and tolerability of finasteride 1\u00a0mg in men aged 41\u201360\u00a0years with male pattern hair loss. Eur J Dermatol 13(2):150\u2013160","journal-title":"Eur J Dermatol"},{"key":"3763_CR8","doi-asserted-by":"crossref","unstructured":"Gormley GJ et\u00a0al (1992) The effect of finasteride in men with benign prostatic hyperplasia. N\u00a0Engl J Med 327(17):1185\u20131191","DOI":"10.1056\/NEJM199210223271701"},{"key":"3763_CR9","doi-asserted-by":"crossref","unstructured":"Thompson IM et\u00a0al (2003) The influence of finasteride on the development of prostate cancer. N\u00a0Engl J Med 349(3):215\u2013224","DOI":"10.1056\/NEJMoa030660"},{"key":"3763_CR10","first-page":"22","volume":"14","author":"Civantos","year":"1996","unstructured":"Civantos F, Soloway MS, Pinto JE (1996) Histopathological effects of androgen deprivation in prostatic cancer. Semin Urol Oncol 14(2 Suppl\u00a02):22\u201331","journal-title":"Semin Urol Oncol"},{"key":"3763_CR11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.urology.2005.07.036","volume":"66","author":"Rubin","year":"2005","unstructured":"Rubin MA et\u00a0al (2005) Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. Urology 66(5):930\u2013934","journal-title":"Urology"},{"key":"3763_CR12","doi-asserted-by":"crossref","unstructured":"Vastag B (2008) Preventing prostate cancer: new analyses put finasteride back on the map. J\u00a0Natl Cancer Inst 100(16):1132\u20131133","DOI":"10.1093\/jnci\/djn300"},{"key":"3763_CR13","doi-asserted-by":"crossref","unstructured":"Kramer BS et\u00a0al (2009) Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology\/American Urological Association 2008 Clinical Practice Guideline. J\u00a0Urol 181(4):1642\u20131657","DOI":"10.1016\/j.juro.2009.01.071"},{"key":"3763_CR14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1529-8019.2010.01358.x","volume":"23","author":"Lynn","year":"2010","unstructured":"Lynn R, Krunic A (2010) Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatol Ther 23(5):544\u2013546","journal-title":"Dermatol Ther"},{"key":"3763_CR15","doi-asserted-by":"crossref","unstructured":"Green L, Wysowski DK, Fourcroy JL (1996) Gynecomastia and breast cancer during finasteride therapy. N\u00a0Engl J Med 335(11):823","DOI":"10.1056\/NEJM199609123351116"},{"key":"3763_CR16","first-page":"3","volume":"3","author":"Medicines","year":"2009","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA) (2009) The risk of male breast cancer with finasteride. Drug Safety Update 3:3","journal-title":"Drug Safety Update"},{"key":"3763_CR17","doi-asserted-by":"crossref","unstructured":"Shenoy NK, Prabhakar SM (2010) Finasteride and male breast cancer: does the MHRA report show a link? J\u00a0Cutan Aesthet Surg 3(2):102\u2013105","DOI":"10.4103\/0974-2077.69022"},{"key":"3763_CR18","doi-asserted-by":"crossref","unstructured":"Eun HC et\u00a0al (2010) Efficacy, safety, and tolerability of dutasteride 0.5\u00a0mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase\u00a0III study. J\u00a0Am Acad Dermatol 63(2):252\u2013258","DOI":"10.1016\/j.jaad.2009.09.018"},{"key":"3763_CR19","doi-asserted-by":"crossref","unstructured":"Gubelin Harcha W et\u00a0al (2014) A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J\u00a0Am Acad Dermatol 70(3):489\u2013498.e3","DOI":"10.1016\/j.jaad.2013.10.049"},{"key":"3763_CR20","doi-asserted-by":"crossref","unstructured":"Overstreet JW et\u00a0al (1999) Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J\u00a0Urol 162:1295\u20131300","DOI":"10.1016\/S0022-5347(05)68270-5"},{"key":"3763_CR21","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2013.07.2000","volume":"100","author":"Samplaski","year":"2013","unstructured":"Samplaski MK et\u00a0al (2013) Finasteride use in the male infertility population: effects on semen and hormone parameters. Fertil Steril 100(6):1542\u20131546","journal-title":"Fertil Steril"},{"key":"3763_CR22","unstructured":"Gebhardt U (2014) Finasterid: Haarpracht auf Kosten der Fruchtbarkeit? http:\/\/www.medscapemedizin.de\/artikel\/4901885"},{"key":"3763_CR23","doi-asserted-by":"crossref","unstructured":"Olsen EA et\u00a0al (2002) A randomized clinical trial of 5\u2009% topical minoxidil versus 2\u2009% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J\u00a0Am Acad Dermatol 47(3):377\u2013385","DOI":"10.1067\/mjd.2002.124088"},{"key":"3763_CR24","doi-asserted-by":"crossref","unstructured":"Yano K, Brown LF, Detmar M (2001) Control of hair growth and follicle size by VEGF-mediated angiogenesis. J\u00a0Clin Invest 107:409\u2013417","DOI":"10.1172\/JCI11317"},{"key":"3763_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000079595","volume":"209","author":"Arca","year":"2004","unstructured":"Arca E et\u00a0al (2004) An open, randomized, comparative study of oral finasteride and 5\u2009% topical minoxidil in male androgenetic alopecia. Dermatology 209(2):117\u2013125","journal-title":"Dermatology"},{"key":"3763_CR26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archderm.139.9.1219-b","volume":"139","author":"Saraswat","year":"2003","unstructured":"Saraswat A, Kumar B (2003) Minoxidil vs finasteride in the treatment of men with androgenetic alopecia. Arch Dermatol 139(9):1219\u20131221","journal-title":"Arch Dermatol"},{"key":"3763_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2009.09186.x","volume":"161","author":"Yip","year":"2009","unstructured":"Yip L et\u00a0al (2009) Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol 161(2):289\u2013294","journal-title":"Br J Dermatol"},{"key":"3763_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","volume":"144","author":"Birch","year":"2001","unstructured":"Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 144:297\u2013304","journal-title":"Br J Dermatol"},{"key":"3763_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2011.10630.x","volume":"165","author":"Sinclair","year":"2011","unstructured":"Sinclair R et\u00a0al (2011) Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol 165(Suppl\u00a03):12\u201318","journal-title":"Br J Dermatol"},{"key":"3763_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","volume":"97","author":"Ludwig","year":"1977","unstructured":"Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247\u2013254","journal-title":"Br J Dermatol"},{"key":"3763_CR31","doi-asserted-by":"crossref","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N\u00a0Engl J Med 352(12):1223\u20131236","DOI":"10.1056\/NEJMra041536"},{"key":"3763_CR32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","volume":"152","author":"Sinclair","year":"2005","unstructured":"Sinclair R, Wewerinke M, Jolley D (2005) Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 152:466\u2013473","journal-title":"Br J Dermatol"},{"key":"3763_CR33","doi-asserted-by":"crossref","unstructured":"Price VH (1999) Treatment of hair loss. N\u00a0Engl J Med 341(13):964\u2013973","DOI":"10.1056\/NEJM199909233411307"},{"key":"3763_CR34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","volume":"146","author":"Vexiau","year":"2002","unstructured":"Vexiau P et\u00a0al (2002) Effects of minoxidil 2\u2009% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 146:992\u2013999","journal-title":"Br J Dermatol"},{"key":"3763_CR35","doi-asserted-by":"crossref","unstructured":"Lucky AW et\u00a0al (2004) A randomized, placebo-controlled trial of 5 and 2\u2009% topical minoxidil solutions in the treatment of female pattern hair loss. J\u00a0Am Acad Dermatol 50(4):541\u2013553","DOI":"10.1016\/j.jaad.2003.06.014"},{"key":"3763_CR36","doi-asserted-by":"crossref","unstructured":"Blume-Peytavi U et\u00a0al (2007) Vergleich der Wirksamkeit und Sicherheit von Minoxidil und Alfatradiol bei der topischen Behandlung der androgenetischen Alopezie der Frau. J\u00a0Dtsch Dermatol Ges 5(5):391\u2013395","DOI":"10.1111\/j.1610-0387.2007.06295.x"},{"key":"3763_CR37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-2133.2012.11166.x","volume":"167","author":"Zuuren","year":"2012","unstructured":"Zuuren EJ van, Fedorowicz Z, Carter\u00a0B (2012) Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. Br J Dermatol 167(5):995\u20131010","journal-title":"Br J Dermatol"},{"key":"3763_CR38","doi-asserted-by":"crossref","unstructured":"Yano K, Detmar M (2003) Thrombospondin-1 plays a critical role in the induction of hair follicle involution and vascular regression during the catagen phase. J\u00a0Invest Dermatol 120:14\u201319","DOI":"10.1046\/j.1523-1747.2003.12045.x"},{"key":"3763_CR39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","volume":"150","author":"Messenger","year":"2004","unstructured":"Messenger AG, Rundegren J (2004) Minoxidil: mechanisms of action on hair growth. Br J Dermatol 150(2):186\u2013194","journal-title":"Br J Dermatol"},{"key":"3763_CR40","doi-asserted-by":"crossref","unstructured":"Dawber RP, Rundegren J (2003) Hypertrichosis in females applying minoxidil topical solution and in normal controls. J\u00a0Eur Acad Dermatol Venereol 17(3):271\u2013275","DOI":"10.1046\/j.1468-3083.2003.00621.x"},{"key":"3763_CR41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00105-003-0560-z","volume":"54","author":"Freyschmidt-Paul","year":"2003","unstructured":"Freyschmidt-Paul P, Happle R, Hoffmann R (2003) Alopecia areata. Klinik, Pathogenese und rationale Therapie einer T-Zell-vermittelten Autoimmunerkrankung. Hautarzt 54(8):713\u2013722","journal-title":"Hautarzt"},{"key":"3763_CR42","doi-asserted-by":"crossref","unstructured":"Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N\u00a0Engl J Med 366(16):1515\u20131525","DOI":"10.1056\/NEJMra1103442"},{"key":"3763_CR43","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","volume":"6","author":"Betz","year":"2015","unstructured":"Betz RC et\u00a0al (2015) Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun 6:5966","journal-title":"Nat Commun"},{"key":"3763_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s001050050738","volume":"49","author":"Volkmar","year":"1998","unstructured":"Volkmar C, Wolff H (1998) Aseptische H\u00fcftkopfnekrose \u2013 Folge innerlicher Kortikosteroidtherapie? Hautarzt 49:261\u2013262","journal-title":"Hautarzt"},{"key":"3763_CR45","first-page":"831","volume":"92","author":"Steen","year":"1995","unstructured":"Steen P van der et\u00a0al (1995) Alopecia areata. Klinik, Pathogenese und topische Immuntherapie. Dtsch Arztebl 92(12\u00a0A):831\u2013836","journal-title":"Dtsch Arztebl"},{"key":"3763_CR46","doi-asserted-by":"crossref","unstructured":"Tosti A, Bellavista S, Iorizzo M (2006) Alopecia areata: a long term follow-up study of 191\u00a0patients. J\u00a0Am Acad Dermatol 55(3):438\u2013441","DOI":"10.1016\/j.jaad.2006.05.008"},{"key":"3763_CR47","doi-asserted-by":"crossref","unstructured":"Craiglow BG, King BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J\u00a0Invest Dermatol 134(12):2988\u20132990","DOI":"10.1038\/jid.2014.260"},{"key":"3763_CR48","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"Xing","year":"2014","unstructured":"Xing L et\u00a0al (2014) Alopecia areata is driven by cytotoxic T\u00a0lymphocytes and is reversed by JAK inhibition. Nat Med 20(9):1043\u20131049","journal-title":"Nat Med"},{"key":"3763_CR49","doi-asserted-by":"crossref","unstructured":"Elewski BE (2000) Tinea capitis: a current perspective. J\u00a0Am Acad Dermatol 42:1\u201320","DOI":"10.1016\/S0190-9622(00)90001-X"},{"key":"3763_CR50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2001-18674","volume":"27","author":"Manz","year":"2001","unstructured":"Manz B, Haustein U-F, Nenoff P (2001) Tinea capitis \u2013 ein aktueller \u00dcberblick. Akt Dermatol 27:295\u2013305","journal-title":"Akt Dermatol"},{"key":"3763_CR51","first-page":"235","volume":"136","author":"Sperling","year":"2000","unstructured":"Sperling LC, Solomon AR, Whiting DA (2000) A new look at scarring alopecia. Arch Dermatol 136:235\u2013242","journal-title":"Arch Dermatol"},{"key":"3763_CR52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1365-2133.1999.02675.x","volume":"140","author":"Powell","year":"1999","unstructured":"Powell JJ, Dawber RPR, Gatter K (1999) Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 140:328\u2013333","journal-title":"Br J Dermatol"},{"key":"3763_CR53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00105-013-2577-2","volume":"64","author":"Tr\u00fceb","year":"2013","unstructured":"Tr\u00fceb RM (2013) Vernarbende Alopezien. Hautarzt 64:810\u2013819","journal-title":"Hautarzt"},{"key":"3763_CR54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2001-19129","volume":"27","author":"Stockmeier","year":"2001","unstructured":"Stockmeier M et\u00a0al (2001) Folliculitis decalvans \u2013 Behandlung mit einer systemischen Rifampicin-Clindamycin-Kombinationstherapie bei 17\u00a0Patienten. Akt Dermatol 27:361\u2013363","journal-title":"Akt Dermatol"},{"key":"3763_CR55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1524-4725.1999.08100.x","volume":"25","author":"Chui","year":"1999","unstructured":"Chui CT et\u00a0al (1999) Recalcitrant scarring follicular disorders treated by laser-assisted hair removal: a preliminary report. Dermatol Surg 25:34\u201337","journal-title":"Dermatol Surg"},{"key":"3763_CR56","doi-asserted-by":"crossref","unstructured":"Mehregan DA, Hale HM van, Muller SA (1992) Lichen planopilaris: clinical and pathologic study of forty-five patients. J\u00a0Am Acad Dermatol 27:935\u2013942","DOI":"10.1016\/0190-9622(92)70290-V"},{"key":"3763_CR57","doi-asserted-by":"crossref","unstructured":"Tan E et\u00a0al (2004) Primary cicatricial alopecias: clinicopathology of 112\u00a0cases. J\u00a0Am Acad Dermatol 50(1):25\u201332","DOI":"10.1016\/j.jaad.2003.04.001"},{"key":"3763_CR58","doi-asserted-by":"crossref","unstructured":"Le Cleach L, Chosidow O (2012) Clinical practice. Lichen planus. N\u00a0Engl J Med 366(8):723\u2013732","DOI":"10.1056\/NEJMcp1103641"},{"key":"3763_CR59","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archdermatol.2009.283","volume":"145","author":"Mirmirani","year":"2009","unstructured":"Mirmirani P, Karnik P (2009) Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol 145(12):1363\u20131366","journal-title":"Arch Dermatol"},{"key":"3763_CR60","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archderm.1994.01690060100013","volume":"130","author":"Kossard","year":"1994","unstructured":"Kossard S (1994) Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 130:770\u2013774","journal-title":"Arch Dermatol"},{"key":"3763_CR61","doi-asserted-by":"crossref","unstructured":"Kossard S, Lee MS, Wilkinson B (1997) Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J\u00a0Am Acad Dermatol 36:59\u201366","DOI":"10.1016\/S0190-9622(97)70326-8"},{"key":"3763_CR62","doi-asserted-by":"crossref","unstructured":"Vano-Galvan S et\u00a0al (2014) Frontal fibrosing alopecia: a multicenter review of 355\u00a0patients. J\u00a0Am Acad Dermatol 70(4):670\u2013678","DOI":"10.1016\/j.jaad.2013.12.003"},{"key":"3763_CR63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s001050100273","volume":"53","author":"Stockmeier","year":"2002","unstructured":"Stockmeier M et\u00a0al (2002) Frontale fibrosierende Alopezie Kossard bei einem Mann. Hautarzt 53:409\u2013411","journal-title":"Hautarzt"},{"key":"3763_CR64","doi-asserted-by":"crossref","unstructured":"MacDonald A, Clark C, Holmes S (2012) Frontal fibrosing alopecia: a review of 60\u00a0cases. J\u00a0Am Acad Dermatol 67(5):955\u2013961","DOI":"10.1016\/j.jaad.2011.12.038"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3763-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-015-3763-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3763-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:39:15Z","timestamp":1718084355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-015-3763-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,19]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3763"],"URL":"https:\/\/doi.org\/10.1007\/s00108-015-3763-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,19]]}}}